Invivyd (IVVD) Return on Equity [ROE] (2021 - 2026)
Invivyd's Return on Equity [ROE] came in at -39.97% for Q2 2026, up 194.25 percentage points from -234.22% a year earlier.
Powered by 
Analysis
Invivyd (IVVD) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Invivyd's Return on Equity [ROE] was -35.95%, up 108.43 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of +56.14 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -144.38% in FY2024 (-64.62 pp), -79.77% in FY2023 (-25.49 pp), -54.27% in FY2022 (+37.82 pp) and -92.09% in FY2021.
- The five-year range for quarterly Return on Equity [ROE] is -242.77% (Q1 2025) to -33.21% (Q4 2025).
- Year-over-year, Return on Equity [ROE] increased in three of the last seven quarters, with an average year-over-year change of +2.98 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2025 (a gain of 201.53 percentage points), and the weakest in Q3 2024 (a drop of 139.70 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Invivyd | 256.44 Mn | -250.20 Mn | 13.01 Mn | -39.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -39.97% |
| Dec 31, 2025 | -33.21% |
| Sep 30, 2025 | -91.62% |
| Jun 30, 2025 | -234.22% |
| Mar 31, 2025 | -242.77% |
| Dec 31, 2024 | -234.74% |
| Sep 30, 2024 | -209.47% |
| Jun 30, 2024 | -134.83% |
| Mar 31, 2024 | -123.48% |
| Dec 31, 2023 | -100.37% |
| Sep 30, 2023 | -69.77% |
| Jun 30, 2023 | -61.97% |
| Mar 31, 2023 | -54.59% |
| Dec 31, 2022 | -67.64% |
| Sep 30, 2022 | -71.42% |
| Jun 30, 2022 | -67.70% |
| Mar 31, 2022 | -56.78% |
| Dec 31, 2021 | -38.08% |
API Access
Invivyd Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IVVD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();